PLASMINOGEN-SUBSTITUTIVE THERAPY IN PLASMINOGEN DEFICIENCY

• 1. 用于除去血纤蛋白原的过滤介质,用于除去血纤蛋白原的过滤装置和使用该装置除去血纤蛋白原的方法 [P] . 中国专利： CN100343667C . 2007.10.17
• 2. 用于除去血纤蛋白原的过滤介质,用于除去血纤蛋白原的过滤装置和使用该装置除去血纤蛋白原的方法 [P] . 中国专利： CN1742200A . 2006-03-01
• 3. Plasminogen replacement therapy for plasminogen deficiency [P] . JP6878423B2 . 2021-05-26

  机译： 纤溶酶原缺乏症的纤溶酶原替代疗法

• 4. PLASMINOGEN REPLACEMENT THERAPY FOR PLASMINOGEN-DEFICIENCY [P] . ZA201802820B . 2019-07-31

  机译： 溶酶原缺乏症的溶酶原替代治疗

• 5. PLASMINOGEN REPLACEMENT THERAPY FOR PLASMINOGEN-DEFICIENCY [P] . 美国专利： US2019231854A1 . 2019-08-01

  机译： 溶酶原缺乏症的溶酶原替代治疗

• 1. Clinical Observation on the Treatment of Insomnia in Germany with Deficiency of Heart and Spleen by the Ear Bean Therapy [J] . XIONG Hang, MA Shu-hui, LI Yuan-yuan, 世界中西医结合杂志（英文） . 2020,第009期
• 2. Clinical Observation on the Treatment of Insomnia in Germany with Deficiency of Heart and Spleen by the Ear Bean Therapy [J] . 熊航, 马淑惠, 李媛媛, 世界中西医结合杂志（英文） . 2020,第009期
• 3. Effect of Antiretroviral Therapy Medications for Acquired Immune Deficiency Syndrome on Serum Elemental Concentrations [J] . ZHANG Peng, CHEN Cheng, LIU Li Ying 生物医学与环境科学（英文版） . 2020,第007期
• 4. Replacement Therapy with Glu-Plasminogen for the Treatment of Severe Respiratory and Auditory Complications of Congenital Plasminogen Deficiency [J] . Tenbrock Klaus, Lehmann Sylvia, Schrading Simone, Acta Haematologica . 2019,第3期
• 5. Human Plasminogen Replacement Therapy Vs. Best Supportive Care in Patients with Congenital Plasminogen Deficiency: A Comparison of Health Care Resource Use over a 48-Week Period [J] . Dranitsaris George, Ortiz Amparo Santamaria, Dorward Kristine, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期
• 6. Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency [J] . Shapiro Amy D., Nakar Charles, Parker Joseph M., Blood: The Journal of the American Society of Hematology . 2018,第12期
• 7. A Mathematical Model of Plasminogen Activation and Fibrinogenolysis during Thrombolytic Therapy with t-PA [C] . Barbara Boniollo, Karl Thomaseth 1995 IEEE engineering in medicine and biology 17th annual conference and 21st Canadian medical and biological engineering conference . 1997
• 8. Targeting GUCY2C for anti-obesity pharmacotherapy Uroguanylin Replacement Opposes Obesity by Restoring Anorexigenic GUCY2C Signaling Silenced by Overnutrition-Induced Uroguanylin Deficiency. [D] . Kim, Gilbert W. 2015
• 9. Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency [O] . Amy D. Shapiro, Charles Nakar, Joseph M. Parker, -1
• 10. Intravenous recombinant tissue plasminogen activator therapy in a 14-week pregnant woman with embolic stroke due to protein S deficiency [O] . Hiroko Hori, Fumio Yamamoto, Yasuyuki Ito, 2013

• 1. Paraesophageal hernia and iron deficiency anemia:Mechanisms,diagnostics and therapy [J] . Christoph G Dietrich ,Dolores Hübner ,Joachim W Heise . 世界胃肠外科杂志：英文版（电子版） . 2021,第3期
• 2. Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind [J] . Marco Infante ,Martina Leoni ,Massimiliano Caprio . 世界糖尿病杂志:英文版(电子版) . 2021,第7期
• 3. 糖尿病凝血、纤溶的改变与血瘀证的关系——凝血酶-抗凝血酶Ⅲ复合物、血浆纤溶酸-α<,2>抗纤溶酶抑制剂和单核细胞促凝活性和纤溶组分的表达 [C] . 陈剑秋 ,施赛珠 ,石志芳 . 第五次全国中医药防治糖尿病学术会议 . 1999
• 4. 海洋微生物来源吲哚酮纤溶化合物影响纤溶因子构象特性的研究 [A] . 洪少彤 . 2015